Chimeric Antigen Receptor T-Cell Therapy in Glioblastoma: Current and Future

Glioblastoma (GBM) is a highly aggressive glioma with an extremely poor prognosis after conventional treatment. Recent advances in immunotherapy offer hope for these patients with incurable GBM. Our present review aimed to provide an overview of immunotherapy for GBM, especially chimeric antigen rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Long, Zhu, Xiqun, Qian, Yu, Yuan, Xiangling, Ding, Yi, Hu, Desheng, He, Xin, Wu, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669545/
https://www.ncbi.nlm.nih.gov/pubmed/33224149
http://dx.doi.org/10.3389/fimmu.2020.594271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669545/
https://www.ncbi.nlm.nih.gov/pubmed/33224149
http://dx.doi.org/10.3389/fimmu.2020.594271

Ejemplares similares